MedPath

Aqueous Calamine Cream BP

Marketing Authorization Holder: Thornton & Ross Ltd. Linthwaite Laboratories Huddersfield HD7 5QH

Authorised
Legal Category

General Sales List

ATC Code

Not classified

Authorization Number

PL 00240/6276R

Summary of Product Characteristics

Detailed prescribing information and pharmaceutical guidance from the UK Electronic Medicines Compendium.

Composition

Active and inactive ingredients

Calamine 4.0% w/w and Zinc Oxide 3.0% w/w **Excipient(s) with specified warnings** Cetostearyl alcohol 4.0% w/w For the full list of excipients, see section 6.1.

Pharmaceutical Form

Dosage form and administration route

Cream

Clinical Particulars

Therapeutic indications and usage

4.1 Therapeutic indications For relief of the symptoms of mild sunburn and other minor skin conditions.4.2 Posology and method of administration Topical application. Adults, elderly and children: apply liberally to dry, clean skin as required.4.3 Contraindications Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1.4.4 Special warnings and precautions for use For external use only. Keep securely closed when not in use. Keep out of the sight and reach of children. Instruct patients not to smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it. **Ingredients with specified warnings** This medicine contains Cetostearyl alcohol which may cause local skin reactions (e.g. contact dermatitis).4.5 Interaction with other medicinal products and other forms of interaction May mask x-ray pictures under certain circumstances.4.6 Fertility, pregnancy and lactation No information is available on the use of this product during pregnancy and lactation. However, it is unlikely that its use would cause any adverse effects.4.7 Effects on ability to drive and use machines None known4.8 Undesirable effects Occasional hypersensitivity or irritant reactions **Reporting of suspected adverse reactions** Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for 'MHRA Yellow Card' in the Google Play or Apple App Store.4.9 Overdose Not applicable

Pharmacological Properties

Pharmacodynamics and pharmacokinetics

5.1 Pharmacodynamic properties Both Zinc Oxide and Calamine exhibit a mild astringent action when applied to the skin.5.2 Pharmacokinetic properties None stated.5.3 Preclinical safety data None

Pharmaceutical Particulars

Storage and handling information

6.1 List of excipients Liquid paraffin, glyceryl monostearate, macrogol cetostearyl ether 22, cetostearyl alcohol, phenoxyethanol, purified water6.2 Incompatibilities None known6.3 Shelf life 36 months unopened Use within 12 months of first opening6.4 Special precautions for storage Do not store above 25°C. Do not allow to freeze.6.5 Nature and contents of container 100g: White polyethylene/Aluminium/co-polymer MDPE laminated plastic tube, with polypropylene cap.6.6 Special precautions for disposal and other handling None

Last updated: 04/09/2019

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.